Single-cell analysis reveals inflammatory interactions driving macular degeneration
Manik Kuchroo1, Marcello DiStasio2, Eric Song3
1Department of Neuroscience, Yale University, New Haven, CT, USA.
Nature Communications
|May 5, 2023
Summary
Age-related macular degeneration (AMD) reveals shared early-stage glial activation pathways across neurodegenerative diseases. A microglia-astrocyte signaling axis in late-stage AMD offers a potential therapeutic target for these conditions.
Area of Science:
- Neurobiology
- Ophthalmology
- Immunology
Background:
- Age-related macular degeneration (AMD) shares pathophysiological similarities with other neurodegenerative diseases.
- The retina serves as an accessible model for studying neurodegeneration due to these commonalities.
Purpose of the Study:
- To investigate shared disease progression pathways across neurodegenerative conditions using AMD as a model.
- To identify specific glial cell activation patterns and signaling mechanisms involved in neurodegeneration.
Main Methods:
- Single-nucleus RNA sequencing of human retinal lesions from AMD patients and controls.
- Development of a machine-learning pipeline utilizing data geometry and topology.
- Comparative analysis of single-cell data from Alzheimer's disease and multiple sclerosis.
Main Results:
- Identification of activated glial populations enriched in the early phase of AMD.
- Discovery of a similar glial activation profile in the early stages of Alzheimer's disease and multiple sclerosis.
- Elucidation of a late-stage AMD microglia-astrocyte signaling axis involving interleukin-1β, driving angiogenesis.
Conclusions:
- Shared glial activation states suggest the retina can model therapeutic strategies for neurodegenerative diseases.
- The identified interleukin-1β signaling axis presents a potential therapeutic target for AMD and other neurodegenerative conditions.
